Takaitaccen Bayani
Idan ka sha ƙarin abinci na tsawon makonni shida, na'urar samar da makamashi a cikin ƙwayoyin tsokar ka za ta yi ƙyalli a auna. Sai ka hau keke, ka yi ta tseren har ka gaji, amma ba ka ga wani canji ba. Wannan shi ne sakamakon sabon gwaji da aka gudanar da ubiquinol, wato sifar “mai aiki” na coenzyme Q10. Gwajin ya tunatar da mu cewa abin da ke faruwa a dakin gwaje‑gwaje ba lallai ne ya nuna tasirin a zahiri ba.
Binciken a Taƙaice
Wata ƙungiya daga Jami'ar Loughborough, tare da Stephen Bailey a matsayin marubucin haɗin gwiwa, sun wallafa sakamakon su a European Journal of Applied Physiology (2026; 126(9):4763‑4778). Sun zaɓi maza 54 masu lafiya da kuma masu motsa jiki na yau da kullum, suka raba su gida biyu: 300 mg na ubiquinol a kowace rana ko kuma placebo, tsawon mako shida. Gwajin ya kasance double‑blind tare da ƙungiyoyi masu zaman kansu.
Kafin da bayan shan ƙarin abinci, masu bincike sun auna:
- Hanyoyin numfashin mitochondria a cikin tsokar ƙashi
- Matakan furotin “leak” na ANT1+2 da UCP‑3 a tsoka
- Ayyukan jurewa a gwajin keke mai ƙarfi, ciki har da lokacin jurewa (TLim) da yanayin ɗaukar iskar O₂ (V̇O₂) kinetics
Ubiquinol da Ubiquinone: Menene Banbanci?
Coenzyme Q10 yana da muhimmanci a sarkar canja wutar lantarki ta mitochondria – wato yana taimaka wa ƙwayoyin su juya mai da iskar oxygen zuwa makamashi. Akwai sifofi biyu:
- Ubiquinone: sifar da aka oxidize, ita ce mafi yawan abin da aka yi amfani da shi a binciken ƙarin abinci.
- Ubiquinol: sifar da aka rage; kamar yadda marubuta suka nuna, yana da ƙarin bioavailability fiye da ubiquinone.
Marubutan sun lura cewa binciken da suka gabata suka yi amfani da ubiquinone, kuma ba su ga tasiri kan aikin mitochondria ko ƙarfin juriya ba. Saboda haka, tambayar ita ce: shin ubiquinol – sifar da aka rage – za ta iya samar da tasiri da ubiquinone ba ta iya ba? Wannan gwaji ya yi ƙoƙarin amsa wannan tambaya.
Sakamakon Ban Mamaki: Haɗin Mitochondria Mai Karfi
Matsakaicin matakin CoQ10 a cikin plasma na ƙungiyar da ta karɓi ubiquinol ya tashi sosai idan aka kwatanta da matakin su na asali da kuma na placebo, don haka ƙarin abincin ya shige cikin jini.
Abin da ya fi jan hankali shi ne a cikin tsoka. Ubiquinol ya rage inverse respiratory control ratio (RCR) – ma'aunin yadda mitochondria ke sarrafa numfashi da samar da ATP. Ƙananan ƙima na nuni da ingantaccen oxidative phosphorylation.
| Rukuni | Kafin | Bayan |
|---|---|---|
| Placebo | 0.064 ± 0.034 | 0.072 ± 0.026 |
| Ubiquinol | 0.073 ± 0.039 | 0.044 ± 0.019 |
Bambancin ya kasance statistically significant (P < 0.05). A taƙaice, mitochondria na tsokar maza da suka sha ubiquinol sun nuna haɗin da ya fi kyau bayan makonni shida. Marubutan sun yi kira ga wannan alama a matsayin “mai nuna yiwuwar” ingantaccen aiki, ba tabbatar da inganci ba.
Ƙalubale da Abubuwan Da Za a Kula Da Su
- Rukuni na ubiquinol ya fara da ƙimar RCR kaɗan mafi girma fiye da placebo, don haka bambance‑bambancen na iya kasancewa ƙanana idan aka kwatanta da asali.
- Lambobin da aka bayar sun nuna bambanci mai girma tsakanin mutane, kuma ƙididdigar an yi a kan dukkan maza, ba kawai waɗanda suka ƙare da placebo ba.
Canjin Labari: Babu Ƙaruwa a Ayyukan Jiki
Kodayake an sami ingantaccen haɗin mitochondria, ba a ga wani tasiri a ainihin aikin motsa jiki ba:
- Lokacin jurewa (TLim) a gwajin keke ba ya bambanta tsakanin ƙungiyoyi.
- V̇O₂ na ƙarshe da canjin V̇O₂ tsakanin minti 2 da ƙarshe suma ba su bambanta ba.
- Matakan furotin ANT1+2 da UCP‑3 ba su canza ba tsakanin rukuni.
Wannan na nuna cewa hanyar da ta haifar da ingantaccen RCR ba a fayyace ta a wannan gwaji ba. Dalilan da ke iya haifar da wannan sun haɗa da tasiri mai ƙanƙanta, gwajin da ba ya da ƙarfi ga irin wannan canji, ko kuma mahalarta da ke da lafiyar mitochondria tun da farko. Waɗannan su ne zato, ba ƙarshe ba.
Wanene Ya Ba da Kuɗi?
Wannan binciken wani ɓangare ne na aikin digiri na marubucin farko, kuma Kaneka Pharma Europe da Jami'ar Loughborough ne suka haɗa kuɗi. Kaneka kamfani ne da ke kera ubiquinol. A cewar sanarwar takardar, Kaneka ba ta da tasiri kan fassarar sakamakon ko rubuta takarda. Kamfanin ya gudanar da gwajin samfuran plasma don auna CoQ10, amma ba ta da alaka da ƙididdiga ko ƙarshe.
Abubuwan Da Za a Iya Amfani Da Su
- Matsakaicin ƙarfi: 300 mg na ubiquinol a kowace rana na makonni shida – wannan ne kawai adadin da aka gwada.
- Lokaci da abinci: Takardar ba ta fayyace lokacin da mahalarta suka sha ba. CoQ10 mai narkewa ne a cikin mai, don haka ana ba da shawarar a sha tare da abincin da ke da mai.
- Masu sha’awar: Masu nazarin lafiyar mitochondria da masu amfani da statins na iya samun sha’awa, amma a wannan gwaji ba a binciki waɗannan rukunai ba; mahalarta su ne maza masu lafiya da motsa jiki.
Waɗanda Ya Kamata Su Guje Ko Su Rage Tsammani
- Duk wanda ke son sayen ubiquinol don ƙara juriya: a wannan gwaji, makonni shida ba su haifar da ƙaruwa a TLim ko V̇O₂ kinetics ba.
- Duk wanda ke tsammanin sakamakon zai shafi mata, manya, ko masu cuta: waɗannan rukuni ba a gwada su ba.
- Duk wanda ke kan magunguna ko yana da yanayin lafiya na musamman ya kamata ya tuntuɓi likita kafin fara wani ƙarin abinci.
Kammalawa
Ubiquinol ya ƙara matakin CoQ10 a plasma kuma ya haifar da ingantaccen respiratory control ratio a mitochondria na tsoka. Amma a cikin maza masu lafiya da motsa jiki, wannan bai bayyana a matsayin ƙaruwa a ƙarfin juriya ko a aikin numfashi ba. A yanzu, shi ne abin sha’awa a matakin sel, ba kayan ƙara ƙarfi ba, kuma har yanzu ba a san wa waɗanda za su amfana da shi ba.
Citation: Acton JP, Alsharif NS, Bond JW, et al. Effect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males. Eur J Appl Physiol. 2026;126(9):4763‑4778. DOI: https://doi.org/10.1007/s00421-026-06275-w. PubMed: https://pubmed.ncbi.nlm.nih.gov/42249931/